Hims & Hers Health (HIMS) Change in Cash (2019 - 2026)
Hims & Hers Health (HIMS) posted Change in Cash of -$6.4 million for Q1 2026, up 94.58% sequentially from -$117.2 million in Q4 2025, and down 111.86% YoY from $53.5 million in Q1 2025.
Hims & Hers Health (HIMS) Change in Cash (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Change in Cash for 8 years, with the latest figure at -$6.4 million in Q1 2026.
- Quarterly Change in Cash fell 111.86% year-over-year to -$6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$52.7 million (down 131.2% YoY) and the FY2025 annual result came in at $7.2 million, down 94.21% from the prior year.
- Change in Cash advanced to -$6.4 million in Q1 2026 per HIMS's latest filing, from -$117.2 million in the prior quarter.
- Over five years, Change in Cash peaked at $850.0 million in Q2 2025 and troughed at -$779.2 million in Q3 2025.
- A 5-year average of $8.8 million and a median of $6.7 million in 2022 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 3433.09% in 2025, down 2251.04% in 2025.
- Over 5 years, Change in Cash stood at -$11.2 million in 2022, then soared by 445.49% to $38.7 million in 2023, then soared by 42.41% to $55.1 million in 2024, then slumped by 312.77% to -$117.2 million in 2025, then jumped by 94.58% to -$6.4 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$6.4 million, -$117.2 million, and -$779.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Hims & Hers Health | 7.81 Bn | 6.97 Bn | 480.80 Mn | 387.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 387.55 Mn |
| Mar 31, 2026 | -6.35 Mn |
| Dec 31, 2025 | -117.16 Mn |
| Sep 30, 2025 | -779.17 Mn |
| Jun 30, 2025 | 849.99 Mn |
| Mar 31, 2025 | 53.52 Mn |
| Dec 31, 2024 | 55.07 Mn |
| Sep 30, 2024 | 36.22 Mn |
| Jun 30, 2024 | 24.06 Mn |
| Mar 31, 2024 | 8.57 Mn |
| Dec 31, 2023 | 38.67 Mn |
| Sep 30, 2023 | -7.42 Mn |
| Jun 30, 2023 | 16.67 Mn |
| Mar 31, 2023 | 1.97 Mn |
| Dec 31, 2022 | -11.19 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | 6.75 Mn |
| Mar 31, 2022 | -23.50 Mn |
| Dec 31, 2021 | 7.01 Mn |
| Sep 30, 2021 | -42.37 Mn |